ANKRD32 Activators
ANKRD32 activators encompass a diverse group of chemical compounds that interact with specific signaling pathways, leading to the enhanced activity of ANKRD32. Dibutyryl-cAMP, for example, is a synthetic analog of cAMP that can diffuse into cells and activate protein kinase A (PKA), a key regulator of numerous cellular processes including transcription. PKA activation can phosphorylate transcription factors and co-regulators, enhancing the transcriptional regulatory functions of ANKRD32. Similarly, forskolin, by increasing intracellular cAMP, leads to PKA activation and could also enhance ANKRD32 activity by promoting its interaction with transcriptional complexes.
Other compounds like ionomycin and thapsigargin induce rises in intracellular calcium levels, which can activate calcium-dependent signaling pathways. Such pathways can lead to the phosphorylation or other post-translational modifications of ANKRD32, thus modulating its activity. Compounds such as PMA and Bisindolylmaleimide I target PKC, another family of kinases involved in a wide range of cellular processes, including the regulation of gene expression. Activation of PKC by PMA may result in the phosphorylation of proteins that interact with ANKRD32, enhancing its role in transcriptional regulation. Conversely, Bisindolylmaleimide I's inhibition of PKC may lead to compensatory cellular responses that could enhance ANKRD32 activity through alternative pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates PKA, leading to phosphorylation of downstream targets. ANKRD32 is associated with transcriptional regulation and PKA activation can enhance ANKRD32's role in transcriptional modulation by promoting its interaction with transcriptional machinery. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
H-89 is a PKA inhibitor that can result in compensatory cellular responses, leading to the activation of alternative pathways that may include kinases which could phosphorylate and activate ANKRD32. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly activates adenylyl cyclase, leading to increased cAMP levels and subsequent PKA activation. ANKRD32 function is enhanced by PKA-mediated phosphorylation, implicating forskolin in promoting ANKRD32's role in cellular signaling and transcriptional regulation. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, potentially leading to the activation of calcium-dependent signaling pathways. These pathways could phosphorylate ANKRD32 or modify its conformation, thus enhancing its functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator that can phosphorylate substrates involved in transcriptional regulation. As ANKRD32 has a role in transcriptional processes, PKC-mediated phosphorylation events can enhance ANKRD32's interaction with specific transcriptional complexes. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is a potent inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels of proteins. ANKRD32, being part of the phosphoproteome, could have enhanced activity due to the prevention of its dephosphorylation, maintaining it in an active state. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a specific inhibitor of protein phosphatases PP1 and PP2A, like Calyculin A, leading to sustained protein phosphorylation. This could lead to increased activity of ANKRD32 by maintaining its phosphorylation status, thereby enhancing its functional role. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that activates stress-activated protein kinases such as JNK. This activation can induce phosphorylation events that affect various proteins, including ANKRD32, thereby potentially enhancing its activity in response to cellular stress. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to increased cytosolic calcium levels, which can activate calcium-dependent signaling pathways. These pathways may modulate the function of ANKRD32, leading to its enhanced activity through post-translational modifications. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent, non-selective inhibitor of protein kinases that, paradoxically, can activate certain signaling pathways through inhibition of negative regulatory kinases, potentially leading to the enhancement of ANKRD32's function. | ||||||